This has become the buzz phrase for so many vendors, from Microsoft to SAP and Oracle (stay tuned for a big announcement by Invensys in April--although it may be light years before most pharmaceutical companies can take full advantage of it) that it may elicit groans and eye-rolling, but this recent article by AMR summarizes directions that Oracle and SAP/Lighthammer are taking.
-AMS
